MSN8C: A Promising Candidate for Antitumor Applications as a Novel Catalytic Inhibitor of Topoisomerase II.

Ou, Jie-Bin; Huang, Wei-Hao; Liu, Xing-Zi; Dai, Guo-Yao; Wang, Lu; Huang, Zhi-Shu; Huang, Shi-Liang

Ou, Jie-Bin; Huang, Wei-Hao; Liu, Xing-Zi; Dai, Guo-Yao; Wang, Lu; Huang, Zhi-Shu; Huang, Shi-Liang.

Afiliação

Ou JB; Department of Pharmacy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
Huang WH; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Liu XZ; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Dai GY; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Wang L; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Huang ZS; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Huang SL; Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Guangzhou 510120, China.

Molecules ; 28(14)2023 Jul 24.

Article em En | MEDLINE | ID: mdl-37513470

Assuntos

Antineoplásicos; DNA Topoisomerases Tipo II; Humanos; DNA Topoisomerases Tipo II/metabolismo; Inibidores da Topoisomerase II/farmacologia; Etoposídeo/farmacologia; Linhagem Celular Tumoral; Células HL-60; Antineoplásicos/farmacologia

Palavras-chave

MSN8C; antiproliferation; catalytic inhibitor; mansonone E; topoisomerase II

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Topoisomerases Tipo II / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google